The Mechanism of Simiao Powder in Treating Gouty Arthritis Based on Network Pharmacology

DOI: https://doi.org/10.62517/jlsa.202507103

Author(s)

Shanxiang Hu, Lin Kuang*, Yuchao Lu, Xinyu Han

Affiliation(s)

School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China *Corresponding Author

Abstract

Gouty arthritis is a common clinical disease with high incidence and recurrence rates. The efficacy of Simiao Powder in treating gouty arthritis is reliable, but its mechanism of action is not yet clear. This project utilizes network pharmacology to explore the specific mechanism of action of Simiao Powder in treating gouty arthritis through molecular docking. It investigates the specific process of how traditional Chinese medicine treats diseases with multiple components, multiple targets, and multiple pathways. Thus, it explores potential targets and related mechanisms, providing experimental evidence for the clinical application of Simiao Powder in treating gouty arthritis and enriching the connotation of traditional Chinese medicine theory.

Keywords

Network Pharmacology; Simiao Powder; Gouty Arthritis

References

[1]Tang Feng Research on the Substance Basis of Ma Huang Fu Zi Xi Xin Tang Formula for Antiallergic Rhinitis Based on Network Pharmacology. Southern Medical University, 2015. [2]Gao Shuchun, Tang Ruixin, Zhao Yang, Deng Xueyang, Fu Jiao Exploring the mechanism of action of traditional Chinese medicines Huanglian, Huangqin, and Huangbai in treating dementia based on network pharmacology and molecular docking. Journal of Shanxi Medical University, 2023 (05): 652-662 [230-05-21]. DOI: 0.13753/j.issn. 1007-6611. 2023.05.012. [3]Liu Ting, Zhang Xia, Li Feiyan Progress in Traditional Chinese and Western Medicine Treatment of Acute Gouty Arthritis. Chinese Journal of Emergency Medicine, 2019, 28 (02): 374-376. [4]Yang Xiaochun, Liu Wei, Wu Yuanhao,The latest research progress on the treatment of acute gouty arthritis with traditional Chinese medicine. Chinese Medical Emergency, 2017, Volume 26 (6): 1011-1013. [5]Zhang Xiaoyun, Gu Bing, Li Huanan, Chen Feng, Gan Bin, Li Song Screening of target genes and biological function analysis of active ingredients in Simiao San for the treatment of gouty arthritis. Shandong Medicine, 2021, Volume 61 (24): 54-58. [6]Zhang Yan Exploring the effective ingredients and mechanism of action of Simiao Wan in treating gout based on network pharmacology. Hebei University, 2020. [7]Zhao B, Zhang Q, Liang X, Xie J, Sun Q. Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4/MyD88/NF-κB signalling pathway. Eur J Pharmacol. 2021; 912: 17460. [8]Ruiz-Miyazawa KW, Staurengo-Ferrari L, Mizokami SS, et al. Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome. Inflammopharmacology. Published online May 15,2017. [9]Miras-Moreno B, Sabater-Jara AB, Pedreño MA, Almagro L. Bioactivity of Phytosterols and Their Production in Plant in Vitro Cultures. J Agric Food Chem. 2016;64(38):7049-7058. [10]Zhou Zhiyuan, Lu Qun, Liu Yang, etc Research and development progress of stigmasterol. Contemporary Chinese Medicine, 2015, 22 (24): 15-17. [11]Gabay O, Sanchez C, Salvat C, et al. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. Osteoarthritis Cartilage. 2010;18(1): 106-116. [12]Morgan LV, Petry F, Scatolin M, et al. Investigation of the anti-inflammatory effects of stigmasterol in mice: insight into its mechanism of action. Behav Pharmacol. 2021;32(8):640-651. [13]Li Song Exploring the mechanism of Simiao San in treating gouty arthritis based on network pharmacology and experimental verification. Jiangxi University of Traditional Chinese Medicine, 2022. [14]Li Huidong, Yang Xueyu, Guo Wenfan, Zheng Xuejun, Lu Jigao, Yang Yong The effect of baicalein regulating inflammatory pathway on inflammatory injury in knee osteoarthritis rats. World Journal of Clinical Medicine, 2023, Volume 44 (6): 552-560. [15]Park JS, Lee HJ, Lee DY, et al. Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and invivo. Biomol Ther (Seoul). 2015;23(5):442-448.